TrialBiomolecules2021

Exploring the Role of Alcohol Metabolizing Genotypes in a 12-Week Clinical Trial of Naltrexone for Alcohol Use Disorder.

João M Castaldelli-Maia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.